Considerations on discontinuing natalizumab for the treatment of multiple sclerosis

Joseph R. Berger; Diego Centonze; Giancarlo Comi; Christian Confavreux; Gary Cutter; Gavin Giovannoni; Ralf Gold; Hans Peter Hartung; Fred Lublin; Augusto Miravalle; Xavier Montalban; Paul O'Connor; Tomas Olsson; Chris H. Polman; Olaf Stuve; Jerry S. Wolinsky; Tjalf Ziemssen

doi:10.1002/ana.22083

Considerations on discontinuing natalizumab for the treatment of multiple sclerosis

Joseph R. Berger, Diego Centonze, Giancarlo Comi, Christian Confavreux, Gary Cutter, Gavin Giovannoni, Ralf Gold, Hans Peter Hartung, Fred Lublin, Augusto Miravalle, Xavier Montalban, Paul O'Connor, Tomas Olsson, Chris H. Polman, Olaf Stuve, Jerry S. Wolinsky, Tjalf Ziemssen

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	409-411
Number of pages	3
Journal	Annals of Neurology
Volume	68
Issue number	3
DOIs	https://doi.org/10.1002/ana.22083
Publication status	Published - 2010

ASJC Scopus subject areas

Neurology
Clinical Neurology
Medicine(all)

Access to Document

10.1002/ana.22083

Cite this

Berger, J. R., Centonze, D., Comi, G., Confavreux, C., Cutter, G., Giovannoni, G., Gold, R., Hartung, H. P., Lublin, F., Miravalle, A., Montalban, X., O'Connor, P., Olsson, T., Polman, C. H., Stuve, O., Wolinsky, J. S., & Ziemssen, T. (2010). Considerations on discontinuing natalizumab for the treatment of multiple sclerosis. Annals of Neurology, 68(3), 409-411. https://doi.org/10.1002/ana.22083

Berger, JR, Centonze, D , Comi, G, Confavreux, C, Cutter, G, Giovannoni, G, Gold, R, Hartung, HP, Lublin, F, Miravalle, A, Montalban, X, O'Connor, P, Olsson, T, Polman, CH, Stuve, O, Wolinsky, JS & Ziemssen, T 2010, 'Considerations on discontinuing natalizumab for the treatment of multiple sclerosis', Annals of Neurology, vol. 68, no. 3, pp. 409-411. https://doi.org/10.1002/ana.22083

@article{d62f974e6b9a4ed8b2ff433b2f844fc8,

title = "Considerations on discontinuing natalizumab for the treatment of multiple sclerosis",

author = "Berger, {Joseph R.} and Diego Centonze and Giancarlo Comi and Christian Confavreux and Gary Cutter and Gavin Giovannoni and Ralf Gold and Hartung, {Hans Peter} and Fred Lublin and Augusto Miravalle and Xavier Montalban and Paul O'Connor and Tomas Olsson and Polman, {Chris H.} and Olaf Stuve and Wolinsky, {Jerry S.} and Tjalf Ziemssen",

year = "2010",

doi = "10.1002/ana.22083",

language = "English",

volume = "68",

pages = "409--411",

journal = "Annals of Neurology",

issn = "0364-5134",

publisher = "John Wiley and Sons Inc.",

number = "3",

}

TY - JOUR

T1 - Considerations on discontinuing natalizumab for the treatment of multiple sclerosis

AU - Berger, Joseph R.

AU - Centonze, Diego

AU - Comi, Giancarlo

AU - Confavreux, Christian

AU - Cutter, Gary

AU - Giovannoni, Gavin

AU - Gold, Ralf

AU - Hartung, Hans Peter

AU - Lublin, Fred

AU - Miravalle, Augusto

AU - Montalban, Xavier

AU - O'Connor, Paul

AU - Olsson, Tomas

AU - Polman, Chris H.

AU - Stuve, Olaf

AU - Wolinsky, Jerry S.

AU - Ziemssen, Tjalf

PY - 2010

Y1 - 2010

UR - http://www.scopus.com/inward/record.url?scp=77956377928&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77956377928&partnerID=8YFLogxK

U2 - 10.1002/ana.22083

DO - 10.1002/ana.22083

M3 - Article

C2 - 20818795

AN - SCOPUS:77956377928

SN - 0364-5134

VL - 68

SP - 409

EP - 411

JO - Annals of Neurology

JF - Annals of Neurology

IS - 3

ER -

Considerations on discontinuing natalizumab for the treatment of multiple sclerosis

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this